Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Deferred Tax Assets / Liabilities ₹-19 Cr₹12 Cr₹30 Cr₹41 Cr₹26 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of NATCO PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of NATCO PHARMA is ₹-19 Cr based on Mar2024 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2024₹-19 Cr
Mar2023₹12 Cr
Mar2022₹30 Cr
Mar2021₹41 Cr
Mar2020₹26 Cr

How is Deferred Tax Assets / Liabilities of NATCO PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2024 ₹-19 Cr
Negative
Mar2023 ₹12 Cr
-58.80
Mar2022 ₹30 Cr
-27.12
Mar2021 ₹41 Cr
59.46
Mar2020 ₹26 Cr -

Compare Deferred Tax Assets / Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,567.1 Cr -4.4% 0.9% -17.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,406.0 Cr -2.7% 3.9% 19.8% Stock Analytics
DIVIS LABORATORIES ₹163,113.0 Cr 1% 8.5% 55.3% Stock Analytics
CIPLA ₹121,869.0 Cr -2.6% 3.9% 6.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹111,345.0 Cr -0.7% 2.5% 22.3% Stock Analytics
DR REDDYS LABORATORIES ₹96,801.0 Cr -1.9% 0.9% -7.8% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-4.4%

0.9%

-17.9%

SENSEX

0.6%

6.2%

8.4%


You may also like the below Video Courses